HomeCompareCMDXF vs JNJ

CMDXF vs JNJ: Dividend Comparison 2026

CMDXF yields 1.96% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 JNJ wins by $11.00 in total portfolio value· pulled ahead in Year 10
10 years
CMDXF
CMDXF
● Live price
1.96%
Share price
$2.96
Annual div
$0.06
5Y div CAGR
-50%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$0.19
Full CMDXF calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — CMDXF vs JNJ

📍 JNJ pulled ahead of the other in Year 10

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodCMDXFJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, CMDXF + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
CMDXF pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CMDXF
Annual income on $10K today (after 15% tax)
$166.18/yr
After 10yr DRIP, annual income (after tax)
$0.16/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, JNJ beats the other by $703.45/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CMDXF + JNJ for your $10,000?

CMDXF: 50%JNJ: 50%
100% JNJ50/50100% CMDXF
Portfolio after 10yr
$20.0K
Annual income
$413.99/yr
Blended yield
2.07%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

CMDXF
Analyst Ratings
1
Sell
Consensus: Sell
Altman Z
2.8
Piotroski
5/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CMDXF buys
0
JNJ buys
0
No recent congressional trades found for CMDXF or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricCMDXFJNJ
Forward yield1.96%3.36%
Annual dividend / share$0.06$4.96
Payout ratio50%55%
1-year div growth0%4.2%
5-year div CAGR-50%5.8%
Portfolio after 10y$20.0K$20.0K
Annual income after 10y$0.19$827.78
Total dividends collected$196.00$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare
Analyst consensusSellBuy

Year-by-year: CMDXF vs JNJ ($10,000, DRIP)

YearCMDXF PortfolioCMDXF Income/yrJNJ PortfolioJNJ Income/yrGap
1$10,798$97.75$10,676$355.77+$122.00CMDXF
2$11,603$49.32$11,407$389.39+$196.00CMDXF
3$12,440$24.77$12,198$426.53+$242.00CMDXF
4$13,323$12.41$13,056$467.62+$267.00CMDXF
5$14,262$6.21$13,987$513.12+$275.00CMDXF
6$15,263$3.11$14,998$563.56+$265.00CMDXF
7$16,333$1.55$16,098$619.52+$235.00CMDXF
8$17,477$0.78$17,295$681.69+$182.00CMDXF
9$18,701$0.39$18,599$750.82+$102.00CMDXF
10← crossover$20,011$0.19$20,022$827.78$11.00JNJ

CMDXF vs JNJ: Complete Analysis 2026

CMDXFStock

Computer Modelling Group Ltd., a computer software technology company, develops and licenses reservoir simulation software in Canada and internationally. The company offers CMOST-AI, an intelligent optimization and analysis tool that offers solution for reservoir by combining statistical analysis, machine learning, and non-biased data interpretation; IMEX, a black oil simulator that is used to model primary and secondary oil recovery processes in conventional and unconventional oil and gas reservoirs; GEM, an equation-of-state reservoir simulator for compositional, chemical, and unconventional reservoir modelling; STARS, a thermal and processes reservoir simulator for the modelling of steam, solvents, air, and chemical recovery processes; and CoFlow, a reservoir and production system modelling software that allows reservoir and production engineers to make informed decisions on large integrated oil and gas projects in Canada. It also provides Builder, a pre-processor that simplifies the creation of simulation models by providing a framework for data integration and workflow management between various data sources; Results, a post-processor that helps in enhancing understanding and insight into recovery processes and reservoir performance; WinProp, a fluid property characterization tool; and Autotune artificial intelligence solutions that tune the model for optimal run time. In addition, it offers professional services comprising specialized support, consulting, training, and contract research services. The company was founded in 1978 and is headquartered in Calgary, Canada.

Full CMDXF Calculator →

JNJHealthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this CMDXF vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CMDXF vs SCHDCMDXF vs JEPICMDXF vs OCMDXF vs KOCMDXF vs MAINCMDXF vs ABBVCMDXF vs MRKCMDXF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.